← FDA Drug Approvals (Drugs@FDA)

YULZETY

NDA · New Drug Application · Sponsor: ROSEMONT PHARMS · Approved 2026-10-16

Drug application

FDA Application #

NDA221033

Application type

New Drug Application

Brand name

YULZETY

Generic name

Rivaroxaban

Active ingredients

RIVAROXABAN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ROSEMONT PHARMS

First approval

2026-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown